Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07066280Phase 3Recruiting
Phase 3, randomised, open-label trial in radiation dermatitis (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of acute radiation dermatitis (ARD) of grade 2-5. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07066280.